Avita Medical Inc (RCEL)
Sector • Healthcare Industry • Medical Equipment & Supplies |
Industry • Medical Equipment & Supplies |
Sector • Healthcare |
The company announced rather relevant deterioration in their top-line, all along the fiscal span ending September 30 2022
company reported fourth quarter of 2022 operating shortfall of $-5.908 millions
Published Mar 24 2023
CSIMarket Team / CSIMarket.com
For the July to September 30 2022 period company Diminishing Returns have swelled of $-0.22 per share compare to $-0.19 a year prior and earnings per share improved from $-0.25 per share from the prior reporting period.
Revenues decreased in double digits by -11.762 % to $9.09 millions from $10.30 millions in the same reporting period a year prior and sequentially Revenues advanced by 9.082 % from $8.34 millions.
For the July to September 30 2022 period Avita Medical Inc realized net deficit of $-5.588 million, larger than $-4.718 million a year ago.
Avita Medical Inc is expected to report next financial results on May 11, 2023.
Revenues decreased in double digits by -11.762 % to $9.09 millions from $10.30 millions in the same reporting period a year prior and sequentially Revenues advanced by 9.082 % from $8.34 millions.
For the July to September 30 2022 period Avita Medical Inc realized net deficit of $-5.588 million, larger than $-4.718 million a year ago.
Avita Medical Inc is expected to report next financial results on May 11, 2023.